drugset / Trial / NCT01919190
EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this prospective, blinded assessor, randomized trial is to assess opioid use and patient-reported outcomes of EXPAREL as a foundation in postsurgical pain therapy in Transversus Abdominis Plane (TAP) infiltration in lower abdominal surgical procedures.
Timeline
- Start
- 2013-08
- Primary completion
- 2013-12
- Completion
- 2014-02
Outcome
Outcome not reported
Stopped: “Due to reasons unrelated to safety; primary endpoint signal seen during pre-specified interim analysis.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 266 mg | Other |
Indications
No indication recorded.